# OLANZAPINE
> **ANDA211072** · Abbreviated New Drug Application (Generic) · Sponsor: UBI · Approved 2025-06-11
## Drug
- **FDA Application Number:** ANDA211072
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** OLANZAPINE
- **Generic name:** OLANZAPINE
- **Active ingredients:** OLANZAPINE
- **Dosage form:** POWDER
- **Route:** INTRAMUSCULAR
- **Marketing status:** Prescription
- **Sponsor:** UBI
- **Manufacturer:** UBI Pharma Inc.
- **First approval:** 2025-06-11
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211072)
---
*AI Analytics · CC0 1.0*